Novavax, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

NVAX 1.04 +0.04 (4.00%)
price chart
Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine
GAITHERSBURG, Md., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced that data from a preclinical study of its nanoparticle influenza vaccine candidate with its proprietary Matrix-M™ adjuvant (NanoFlu™) have been ...
Novavax (NVAX) Stock: Gaining On Preclinical Data  CNA Finance (press release)
Novavax: The Case For Going Long
Market confidence in Novavax evaporated in 2016 after the failure of an RSV vaccine trial in the elderly population; investors remain dubious about the prospects of the ongoing maternal trial.
Novavax, Inc.: Buy the Dip?
The results were so encouraging that the Bill & Melinda Gates Foundation awarded Novavax with a grant worth up to $89 million to support further development of the product.
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by ...  Newburgh Gazette
Novavax Inc (NVAX) Buy, Hold or Sell? What Analysts Recommend  ExpertGazette
Why Novavax, Inc Is Tanking Today
First, Novavax said that its phase 3 Prepare trial -- which is studying its respiratory syncytial virus candidate, RSV F Vaccine, in infants via maternal immunization -- continues to progress.
Novavax CEO: 'We have a vaccine we like'  Washington Business Journal
Forget The Shorts And Buy Novavax Inc (NASDAQ:NVAX)  Insider Financial
Novavax Reaching Critical Mass?
Novavax (NVAX) is a $290 million market cap company focused on using recombinant nanoparticle vaccine technology to treat a wide range of infectious disease.
Novavax Reports Second Quarter 2017 Financial Results  GlobeNewswire (press release)
Novavax, Inc. (NVAX) Cut to “Hold” at Zacks Investment Research
According to Zacks, “NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases.
Analyst's Bullish on these two stock Following meeting with Industry ...  StockNewsJournal
The Way Analysts See ConocoPhillips (COP) And Novavax, Inc. (NVAX)  Post Analyst
Today Analysts Focus on Novavax, Inc. (NVAX), Schlumberger Limited (SLB)
Investors who are keeping close eye on the stock of Novavax, Inc. (NASDAQ:NVAX) established that the company was able to keep return on investment at -57.83 in the trailing twelve month while Reuters data showed that industry's average stands at 2.83 ...
Novavax, Inc. (NVAX) while ContraVir Pharmaceuticals, Inc. (CTRV) finishes ...
In recent trading day Novavax, Inc. (NVAX) stock closing price of $1.00. Closing price generally refers to the last price at which a stock trades during a regular trading session.
Top Earnings Today - Disney, Novavax, Inc And Priceline Stock
In today's earnings post we will be covering Walt Disney Co, Novavax Inc and Priceline group. While studios and theme parks are likely to post good numbers for Disney, ESPN numbers and commentary will be the key thing to watch out for.
Why to Keeping Eye on Novavax, Inc. (NVAX), AMC Entertainment Holdings, Inc ...
Novavax, Inc. (NVAX) have shown a high EPS growth of -43.40% in the last 5 years and has earnings decline of -72.80% yoy.